Microglia and Central Nervous System Immunity

Neurosurgery Clinics of North America

Volumn 21, Issue 1, 2010, Pages 43-51

  Kaur, Gurvinder ^a   Han, Seunggu J ^a   Yang, Isaac ^a   Crane, Courtney ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Central nervous system; Glioma immunology; Immunity; Microglia

Indexed keywords

CAFFEIC ACID DERIVATIVE; CPG OLIGODEOXYNUCLEOTIDE; UNCLASSIFIED DRUG; WP 1066;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL STRUCTURE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CHEMOTAXIS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; GLIOMA; HUMAN; IMMUNOSURVEILLANCE; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE FUNCTION; MICROGLIA; NERVE CELL PLASTICITY; NERVE FUNCTION; NONHUMAN; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; TUMOR IMMUNITY;

ANIMALS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM; DISEASE PROGRESSION; GLIOMA; HUMANS; IMMUNE TOLERANCE; INFLAMMATION MEDIATORS; MICROGLIA;

EID: 70450203656     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nec.2009.08.009     Document Type: Review

References (112)

1. Pachter J.S., de Vries H.E., and Fabry Z. The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol 62 6 (2003) 593-604
2. Hao C., Parney I.F., Rao W.H., et al. Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation. Acta Neuropathol (Berl) 103 2 (2002) 171-178
3. Ayoub A.E., and Salm A.K. Increased morphological diversity of microglia in the activated hypothalamic supraoptic nucleus. J Neurosci 23 21 (2003) 7759-7766
4. Sedgwick J.D., Schwender S., Imrich H., et al. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci U S A 88 16 (1991) 7438-7442
5. Aloisi F., De Simone R., Columba-Cabezas S., et al. Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells. J Immunol 164 4 (2000) 1705-1712
6. Hoftberger R., Aboul-Enein F., Brueck W., et al. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol 14 1 (2004) 43-50
7. Carbonell W.S., Murase S.I., Horwitz A.F., et al. Infiltrative microgliosis: activation and long-distance migration of subependymal microglia following periventricular insults. J Neuroinflammation 2 1 (2005) 5
8. Schroeter M., Jander S., Huitinga I., et al. Phagocytic response in photochemically induced infarction of rat cerebral cortex. The role of resident microglia. Stroke 28 2 (1997) 382-386
9. Zhang S.C., Goetz B.D., Carre J.L., et al. Reactive microglia in dysmyelination and demyelination. Glia 34 2 (2001) 101-109
10. Eliason D.A., Cohen S.A., Baratta J., et al. Local proliferation of microglia cells in response to neocortical injury in vitro. Brain Res Dev Brain Res 137 1 (2002) 75-79
11. Liu L., Persson J.K., Svensson M., et al. Glial cell responses, complement, and clusterin in the central nervous system following dorsal root transection. Glia 23 3 (1998) 221-238
12. Aloisi F. Immune function of microglia. Glia 36 2 (2001) 165-179
13. Brannan C.A., and Roberts M.R. Resident microglia from adult mice are refractory to nitric oxide-inducing stimuli due to impaired NOS2 gene expression. Glia 48 2 (2004) 120-131
14. Aloisi F., Ria F., Penna G., et al. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol 160 10 (1998) 4671-4680
15. Aloisi F., Ria F., Columba-Cabezas S., et al. Relative efficiency of microglia, astrocytes, dendritic cells and B cells in naive CD4+ T cell priming and Th1/Th2 cell restimulation. Eur J Immunol 29 9 (1999) 2705-2714
16. Schartner J.M., Hagar A.R., Van Handel M., et al. Impaired capacity for upregulation of MHC class II in tumor-associated microglia. Glia 51 4 (2005) 279-285
17. Bettinger I., Thanos S., and Paulus W. Microglia promote glioma migration. Acta Neuropathol 103 4 (2002) 351-355
18. Benveniste E.N. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med 75 3 (1997) 165-173
19. Lawson L.J., Perry V.H., Dri P., et al. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39 1 (1990) 151-170
20. Lawson L.J., Perry V.H., and Gordon S. Turnover of resident microglia in the normal adult mouse brain. Neuroscience 48 2 (1992) 405-415
21. Del Rio-Hortega P. Microglia. In: Penfield W. (Ed). Cytology and cellular pathology of the nervous system vol. 11 (1932), Paul B Hoeber, New York 481-534
22. Ling E.A., and Wong W.C. The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 7 1 (1993) 9-18
23. Bsibsi M., Ravid R., Gveric D., et al. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61 11 (2002) 1013-1021
24. Olson J.K., and Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173 6 (2004) 3916-3924
25. Akiyama H., and McGeer P.L. Brain microglia constitutively express beta-2 integrins. J Neuroimmunol 30 1 (1990) 81-93
26. Dick A.D., Ford A.L., Forrester J.V., et al. Flow cytometric identification of a minority population of MHC class II positive cells in the normal rat retina distinct from CD45lowCD11b/c+CD4low parenchymal microglia. Br J Ophthalmol 79 9 (1995) 834-840
27. Becher B., and Antel J.P. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 18 1 (1996) 1-10
28. Hess D.C., Abe T., Hill W.D., et al. Hematopoietic origin of microglial and perivascular cells in brain. Exp Neurol 186 2 (2004) 134-144
29. Kennedy D.W., and Abkowitz J.L. Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 90 3 (1997) 986-993
30. Nimmerjahn A., Kirchhoff F., and Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308 5726 (2005) 1314-1318
31. Neumann H., Boucraut J., Hahnel C., et al. Neuronal control of MHC class II inducibility in rat astrocytes and microglia. Eur J Neurosci 8 12 (1996) 2582-2590
32. McCluskey L.P., and Lampson L.A. Local neurochemicals and site-specific immune regulation in the CNS. J Neuropathol Exp Neurol 59 3 (2000) 177-187
33. Hoek R.M., Ruuls S.R., Murphy C.A., et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290 5497 (2000) 1768-1771
34. Wright G.J., Puklavec M.J., Willis A.C., et al. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13 2 (2000) 233-242
35. Schilling M., Besselmann M., Leonhard C., et al. Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol 183 1 (2003) 25-33
36. De Simone R., Ajmone-Cat M.A., Tirassa P., et al. Apoptotic PC12 cells exposing phosphatidylserine promote the production of anti-inflammatory and neuroprotective molecules by microglial cells. J Neuropathol Exp Neurol 62 2 (2003) 208-216
37. Kreuzfelder E., Menne S., Ferencik S., et al. Assessment of peripheral blood mononuclear cell proliferation by [2-3H]adenine uptake in the woodchuck model. Clin Immunol Immunopathol 78 3 (1996) 223-227
38. Tsai J.C., Goldman C.K., and Gillespie G.Y. Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg 82 5 (1995) 864-873
39. Fischer H.G., and Reichmann G. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J Immunol 166 4 (2001) 2717-2726
40. Dheen S.T., Kaur C., and Ling E.A. Microglial activation and its implications in the brain diseases. Curr Med Chem 14 11 (2007) 1189-1197
41. Banati R.B., Gehrmann J., Schubert P., et al. Cytotoxicity of microglia. Glia 7 1 (1993) 111-118
42. Nakamichi K., Saiki M., Sawada M., et al. Double-stranded RNA stimulates chemokine expression in microglia through vacuolar pH-dependent activation of intracellular signaling pathways. J Neurochem 95 1 (2005) 273-283
43. Hartlage-Rubsamen M., Lemke R., and Schliebs R. Interleukin-1beta, inducible nitric oxide synthase, and nuclear factor-kappaB are induced in morphologically distinct microglia after rat hippocampal lipopolysaccharide/interferon-gamma injection. J Neurosci Res 57 3 (1999) 388-398
44. Suzumura A., Sawada M., and Marunouchi T. Selective induction of interleukin-6 in mouse microglia by granulocyte-macrophage colony-stimulating factor. Brain Res 713 1-2 (1996) 192-198
45. Floden A.M., Li S., and Combs C.K. Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors. J Neurosci 25 10 (2005) 2566-2575
46. Babcock A.A., Kuziel W.A., Rivest S., et al. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 23 21 (2003) 7922-7930
47. Si Q., Cosenza M., Zhao M.L., et al. GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia. Glia 39 2 (2002) 174-183
48. Takami S., Nishikawa H., Minami M., et al. Induction of macrophage inflammatory protein MIP-1alpha mRNA on glial cells after focal cerebral ischemia in the rat. Neurosci Lett 227 3 (1997) 173-176
49. Chen C.J., Chen J.H., Chen S.Y., et al. Upregulation of RANTES gene expression in neuroglia by Japanese encephalitis virus infection. J Virol 78 22 (2004) 12107-12119
50. Lu J., Moochhala S., Kaur C., et al. Cellular inflammatory response associated with breakdown of the blood-brain barrier after closed head injury in rats. J Neurotrauma 18 4 (2001) 399-408
51. Tonra J.R., Reiseter B.S., Kolbeck R., et al. Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis. J Comp Neurol 430 1 (2001) 131-144
52. Baldwin A.C., and Kielian T. Persistent immune activation associated with a mouse model of Staphylococcus aureus-induced experimental brain abscess. J Neuroimmunol 151 1-2 (2004) 24-32
53. Peress N.S., Fleit H.B., Perillo E., et al. Identification of Fc gamma RI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease. J Neuroimmunol 48 1 (1993) 71-79
54. Barnum S.R. Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease. Mol Med 5 9 (1999) 569-582
55. Ferrer I., Bernet E., Soriano E., et al. Naturally occurring cell death in the cerebral cortex of the rat and removal of dead cells by transitory phagocytes. Neuroscience 39 2 (1990) 451-458
56. Nguyen K.B., and Pender M.P. Phagocytosis of apoptotic lymphocytes by oligodendrocytes in experimental autoimmune encephalomyelitis. Acta Neuropathol 95 1 (1998) 40-46
57. Chao C.C., Hu S., and Peterson P.K. Modulation of human microglial cell superoxide production by cytokines. J Leukoc Biol 58 1 (1995) 65-70
58. Slavik J.M., Hutchcroft J.E., and Bierer B.E. CD28/CTLA-4 and CD80/CD86 families: signaling and function. Immunol Res 19 1 (1999) 1-24
59. van Kooten C., and Banchereau J. CD40-CD40 ligand. J Leukoc Biol 67 1 (2000) 2-17
60. Stoll M., Capper D., Dietz K., et al. Differential microglial regulation in the human spinal cord under normal and pathological conditions. Neuropathol Appl Neurobiol 32 6 (2006) 650-661
61. Gehrmann J., Matsumoto Y., and Kreutzberg G.W. Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev 20 3 (1995) 269-287
62. Ford A.L., Foulcher E., Lemckert F.A., et al. Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med 184 5 (1996) 1737-1745
63. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19 8 (1996) 312-318
64. De Simone R., Giampaolo A., Giometto B., et al. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol 54 2 (1995) 175-187
65. Li H., Cuzner M.L., and Newcombe J. Microglia-derived macrophages in early multiple sclerosis plaques. Neuropathol Appl Neurobiol 22 3 (1996) 207-215
66. Shrikant P., and Benveniste E.N. The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. J Immunol 157 5 (1996) 1819-1822
67. Pender M.P., and Rist M.J. Apoptosis of inflammatory cells in immune control of the nervous system: role of glia. Glia 36 2 (2001) 137-144
68. Spanaus K.S., Schlapbach R., and Fontana A. TNF-alpha and IFN-gamma render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL. Eur J Immunol 28 12 (1998) 4398-4408
69. Frigerio S., et al. Modulation of fas-ligand (Fas-L) on human microglial cells: an in vitro study. J Neuroimmunol 105 2 (2000) 109-114
70. Kohji T., and Matsumoto Y. Coexpression of Fas/FasL and Bax on brain and infiltrating T cells in the central nervous system is closely associated with apoptotic cell death during autoimmune encephalomyelitis. J Neuroimmunol 106 1-2 (2000) 165-171
71. Rossi M.L., Jones N.R., Candy E., et al. The mononuclear cell infiltrate compared with survival in high-grade astrocytomas. Acta Neuropathol 78 2 (1989) 189-193
72. Roggendorf W., Strupp S., and Paulus W. Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol 92 3 (1996) 288-293
73. Streit W.J. Cellular immune response in brain tumors. Neuropathol Appl Neurobiol 20 2 (1994) 205-206
74. Wierzba-Bobrowicz T., Kuchna I., and Matyja E. Reaction of microglial cells in human astrocytomas (preliminary report). Folia Neuropathol 32 4 (1994) 251-252
75. Badie B., Schartner J.M., Paul J., et al. Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study. J Neurosurg 93 4 (2000) 634-639
76. Prat E., Baron P., Meda L., et al. The human astrocytoma cell line U373MG produces monocyte chemotactic protein (MCP)-1 upon stimulation with beta-amyloid protein. Neurosci Lett 283 3 (2000) 177-180
77. Galasso J.M., Stegman L.D., Blaivas M., et al. Experimental gliosarcoma induces chemokine receptor expression in rat brain. Exp Neurol 161 1 (2000) 85-95
78. Suzuki Y., Funakoshi H., Machide M., et al. Regulation of cell migration and cytokine production by HGF-like protein (HLP)/macrophage stimulating protein (MSP) in primary microglia. Biomed Res 29 2 (2008) 77-84
79. Alterman R.L., and Stanley E.R. Colony stimulating factor-1 expression in human glioma. Mol Chem Neuropathol 21 2-3 (1994) 177-188
80. Badie B., Schartner J., Klaver J., et al. In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. Neurosurgery 44 5 (1999) 1077-1082 [discussion: 1082-3]
81. Morantz R.A., Wood G.W., Foster M., et al. Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. J Neurosurg 50 3 (1979) 305-311
82. Badie B., and Schartner J. Role of microglia in glioma biology. Microsc Res Tech 54 2 (2001) 106-113
83. Proescholdt M.A., Merrill M.J., Ikejiri B., et al. Site-specific immune response to implanted gliomas. J Neurosurg 95 6 (2001) 1012-1019
84. Tran C.T., Wolz P., Egensperger R., et al. Differential expression of MHC class II molecules by microglia and neoplastic astroglia: relevance for the escape of astrocytoma cells from immune surveillance. Neuropathol Appl Neurobiol 24 4 (1998) 293-301
85. Flugel A., Labeur M.S., Grasbon-Frodl E.M., et al. Microglia only weakly present glioma antigen to cytotoxic T cells. Int J Dev Neurosci 17 5-6 (1999) 547-556
86. Badie B., Bartley B., and Schartner J. Differential expression of MHC class II and B7 costimulatory molecules by microglia in rodent gliomas. J Neuroimmunol 133 1-2 (2002) 39-45
87. Magnus T., Schreiner B., Korn T., et al. Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J Neurosci 25 10 (2005) 2537-2546
88. Parsa A.T., Waldron J.S., Panner A., et al. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat Med 13 1 (2007) 84-88
89. Dong H., Strome S.E., Salomao D.R., et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8 8 (2002) 793-800
90. Badie B., Schartner J., Prabakaran S., et al. Expression of Fas ligand by microglia: possible role in glioma immune evasion. J Neuroimmunol 120 1-2 (2001) 19-24
91. Parney I.F., Waldron J.S., and Parsa A.T. Flow cytometry and in vitro analysis of human glioma-associated macrophages. J Neurosurg 110 3 (2009) 572-582
92. Kostianovsky A.M., Maier L.M., Anderson R.C., et al. Astrocytic regulation of human monocytic/microglial activation. J Immunol 181 8 (2008) 5425-5432
93. Parney I.F., Hao C., and Petruk K.C. Glioma immunology and immunotherapy. Neurosurgery 46 4 (2000) 778-791 [discussion: 791-2]
94. Suzumura A., Sawada M., Yamamoto H., et al. Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. J Immunol 151 4 (1993) 2150-2158
95. Hishii M., Nitta T., Ishida H., et al. Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro. Neurosurgery 37 6 (1995) 1160-1166 [discussion: 1166-7]
96. O'Keefe G.M., Nguyen V.T., and Benveniste E.N. Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10. Eur J Immunol 29 4 (1999) 1275-1285
97. Rao J.S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3 7 (2003) 489-501
98. Lafuente J.V., Adan B., Alkiza K., et al. Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas. J Mol Neurosci 13 1-2 (1999) 177-185
99. Hussain S.F., Kong L.Y., Jordan J., et al. A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients. Cancer Res 67 20 (2007) 9630-9636
100. Iwamaru A., Szymanski S., Iwado E., et al. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene 26 17 (2007) 2435-2444
101. Zhang L., Alizadeh D., Van Handel M., et al. Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice. Glia 57 13 (2009) 1458-1467
102. Gabrilovich D.I., Chen H.L., Girgis K.R., et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2 10 (1996) 1096-1103
103. Kortylewski M., Kujawski M., Wang T., et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med 11 12 (2005) 1314-1321
104. Darnell Jr. J.E. STATs and gene regulation. Science 277 5332 (1997) 1630-1635
105. Raizer J.J. HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme. J Neurooncol 74 1 (2005) 77-86
106. Salomon D.S., Brandt R., Ciardiello F., et al. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19 3 (1995) 183-232
107. Tang P., Steck P.A., and Yung W.K. The autocrine loop of TGF-alpha/EGFR and brain tumors. J Neurooncol 35 3 (1997) 303-314
108. Schaefer L.K., Ren Z., Fuller G.N., et al. Constitutive activation of Stat3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2). Oncogene 21 13 (2002) 2058-2065
109. Yu H., and Jove R. The STATs of cancer-new molecular targets come of age. Nat Rev Cancer 4 2 (2004) 97-105
110. Carpentier A.F., Xie J., Mokhtari K., et al. Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs. Clin Cancer Res 6 6 (2000) 2469-2473
111. Carpentier A.F., Auf G., and Delattre J.Y. CpG-oligonucleotides for cancer immunotherapy: review of the literature and potential applications in malignant glioma. Front Biosci 8 (2003) e115-e127
112. Auf G., Carpentier A.F., Chen L., et al. Implication of macrophages in tumor rejection induced by CpG-oligodeoxynucleotides without antigen. Clin Cancer Res 7 11 (2001) 3540-3543